Human Prion Diseases
Ann Neurol 35:385-395, Prusiner,S.B.&Hsiao,K.K., 1994
Migraine:A Pharmacologic Review with Newer Options and Delivery Modalities
Neurol 44:S13-S17, Baumel,B., 1994
Subcutaneous Sumatriptan During the Migraine Aura
Neurol 44:1587-1592, Bates,D.,et al, 1994
Diagnosis and Management of Pituitary Tumours
BMJ 308:1087-1091, Levy,A.&Lightman,S.L., 1994
A Multicenter Double-Blind Placebo-Controlled Trial of Pergolide as an Adjunct to Sinemet in Parkinson's Disease
Movement Disorders, 9:40-471994., Olanow,C.W.,et al, 1994
Parkinson's Disease
JNNP 57:672-681, Marsden,C.D., 1994
Oral Contraception and Stroke
Stroke 25:935-942, Hannaford,P.C.,et al, 1994
Practice Advisory on Selection of Patients with Multiple Sclerosis for Treatment with Betaseron
Neurol 44:1537-1540, Alter,M.,et al, 1994
Are Magnetic Resonance Findings Pred of Clinical Outcome in Therapeutic Trials in MS? The Dilemma of Interferon-B
Ann Neurol 36:14-18, McDonald,W.I.,et al, 1994
Drug Therapy of Migraine
NEJM 329:1476-1483, Welch,K.M.A., 1993
Prolactin-Secreting Macroadenomas in Adolescents, Response to Bromocriptine Therapy
Am J Dis Child 147:1057-1061, Tyson,D.,et al, 1993
Acromegaly:Treatment After 100 Years
BMJ 307:1505-1506, Wass,J.A.H., 1993
Postmarketing Study of Cardiovascular Adverse Reactions Associated with Sumatriptan
BMJ 307:1185, Ottervanger,J.P.,et al, 1993
Epilepsy and Pregnancy
BMJ 307:492-495, O'Brien,M.D.&Gilmour-White,S., 1993
Computed Tomographic Evidence of an Extensive Thrombosis and Infarction of the Deep Venous System
Stroke 24:744-746, Ur-Rahman,N.&Al-Tahan,A.R., 1993
Cabergoline in Parkinson's Disease:Long-Term Follow-up
Neurol 43:2587-2590, Lera,G.,et al, 1993
Multictr Study of Cabergoline, A Long-Acting Dopamine Receptor Agonist, in PD Fluct Resp to Levodopa/Carbidopa
Neurol 43:1981-1984, Lieberman,A.,et al, 1993
Sumatriptan
Lancet 341:221-224, Bateman,D.N., 1993
Oral Contraception and Risk of a Cerebral Thromboembolis Attack:Results of a Case-Control Study
BMJ 306:956-963, Kidegaard,O., 1993
Interferon Beta-1b is Effective in Relapsing-Remitting MS
Clinical Results of a Placebo-Controlled Trial, IFNB MS Study Grp, Neurol 43:655-661, 64193., , 1993
Interferon Beta-1b is Effective in Relapsing Remitting MS, MRI Analysis Results of Placebo-Control Trial
Neurol 43:662-667, 6411993., Paty,D.W.,et al, 1993
Clinicopath Conf
Spongiform Encephalopathy (Creutzfeldt-Jakob Disease) , with Amyloid (KURU) Plaques, Case 17-1993, N, JM 328:66,1993., 1993
Sumatriptan and Chest Pain
Lancet 341:1564-1565, Hillis,W.S.&MacIntyre,P.D., 1993
Transmural Myocardial Infarction with Sumatriptan
Lancet 341:861-862, Ottervanger,J.P.,et al, 1993
Efficacy of Subcutaneous Sumatriptan in Repeated Episodes of Migraine
Neurol 43:1363-1368, Cady,R.K.,et al, 1993
Comparisons of Therapeutic Effects of Levodopa
Levodopa & Selegiline, & Bromocriptine in Pts with Early, Mild Parkinson's, Parkinson's Res Grp in U, , BMJ 372,1993., 1993
Defecatory Function in Parkinson's Disease:Response to Apomorphine
Ann Neurol 33:490-493, Edwards,L.L.,et al, 1993
Sumatriptan for Migraine
The Medical Letter, 34:91-931992., , 1992
Dose Ranging Efficacy & Safety of Subcut Sumatriptan in Acute Treat of Migraine
Arch Neurol 49:1271-1276, Mathew,N.T.,et al, 1992
Coronary Vasospasm Induced by Subcutaneous Sumatriptan
BMJ 304:1415, Willett,F.,et al, 1992
Dopamine Agonist Treatment of Fluctuating Parkinsonisn
Arch Neurol 49:560-568, Ahlskog,J.E.,et al, 1992
Acute Respiratory Failure from Dopamine Agonist Withdrawal
Neurol 42:1843-1844, Riley,D.E.,et al, 1992
Cerebral Venous Thrombosis
Neurol Clin 10:87-111, Ameri,A.&Bousser,M-G., 1992
The Molecular Pathogenesis of Alzheimer's Disease:Clinical Prospects
Lancet 340:1512-1515, Murphy,M., 1992
Sumatriptan:Efficacy and Contribution to Migraine Mechanisms
JNNP 55:1103-1105, Pearce,J.M.S., 1992
An Open-Label Trial of Bromocriptine in Nonfluent Aphasia
Neurol 42:1637-1638, Sabe,L.,et al, 1992
Sumatriptan
Serotonin, Migraine, and Money, Editorial, Lancet 339:151-1522., , 1992
Olanzapine in the Treatment of Dopaminomimetic Psychosis in Patients with Parkinson's Disease
Neurol 47:1085-1087, Wolters,W.Ch.,et al, 1992
Oral Sumatriptan in Acute Migraine
Lancet 338:782-783, Goadsby,P.J.,et al, 1991
A Multi-Center, Double-Blind Study on Slow-Release Bromocriptine in the Treatment of Parkinson's Disease
Neurol 41:1598-1602, Mannen,T.,et al, 1991
Pleuropulmonary Disease Associated with Dopamine Agonist Therapy
Ann Neurol 30:613-616, Bhatt,M.H.,et al, 1991
The Apomorphine Test in Parkinsonian Syndromes
JNNP 54:870-872, D'Costa,D.F.,et al, 1991
Estrogens, Progestins, and Headache
Neurol 41:786-793, Silberstein,S.D.&Merriam,G.R., 1991
Sumatriptan in Migraine, May be Better than Aspirin and Metoclopramide
BMJ 303:1491, Pearce,J.M.S., 1991
Tourette Syndrome and Other Tic Disorders, Diagnosis, Pathophysiology, and Treatment
Medicine 70:15-32, Singer,H.S.&Walkup,J.T., 1991
Cerebral Infarction in Young People, A Study of 148 Patients with Early Cerebral Angiography
JNNP 54:576-579, Lisovoski,F.&Rousseaux,P., 1991
Diagnosis and Management of Hormone-Secreting Pituitary Adenomas
NEJM 324:822-831, Klibanski,A.&Zervas,N.T., 1991
Accelerated Intracranial Occlusive Disease, Oral Contraceptives, and Cigarette Use
Neurol 41:1893-1901, Levine,S.R.,et al, 1991
BA4 Amyloid Protein Deposition in Brain After Head Trauma
Lancet 338:1422-1423, Roberts,G.W.,et al, 1991
Treatment of Acute Migraine with Subcutaneous Sumatriptan
JAMA 265:2831-2835, Cady,R.K.,et al, 1991